NPORT-EX 2 c10899bnymellonu-august20201.htm Untitled Document

STATEMENT OF INVESTMENTS
BNY Mellon U.S. Equity Fund

August 31, 2020 (Unaudited)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 99.0%

     

Capital Goods - 8.4%

     

Donaldson

   

218,800

a

11,018,768

 

Fastenal

   

403,800

 

19,729,668

 

Flowserve

   

238,500

a

7,078,680

 

Hexcel

   

306,700

 

12,080,913

 

The Toro Company

   

174,200

 

13,113,776

 
    

63,021,805

 

Consumer Durables & Apparel - 2.6%

     

NIKE, Cl. B

   

174,400

 

19,513,616

 

Consumer Services - 2.0%

     

McDonald's

   

70,800

 

15,117,216

 

Diversified Financials - 1.9%

     

Intercontinental Exchange

   

136,900

 

14,542,887

 

Energy - .8%

     

EOG Resources

   

136,820

 

6,203,419

 

Health Care Equipment & Services - 12.5%

     

Cerner

   

212,400

 

15,583,788

 

Edwards Lifesciences

   

204,400

b

17,545,696

 

Henry Schein

   

253,800

b

16,862,472

 

Intuitive Surgical

   

22,100

b

16,151,564

 

ResMed

   

89,300

 

16,143,654

 

Stryker

   

59,500

 

11,790,520

 
    

94,077,694

 

Household & Personal Products - 4.1%

     

Colgate-Palmolive

   

195,400

 

15,487,404

 

The Estee Lauder Companies, Cl. A

   

67,000

 

14,855,240

 
    

30,342,644

 

Materials - 7.4%

     

Ecolab

   

88,100

 

17,362,748

 

FMC

   

162,500

 

17,364,750

 

Linde

   

82,800

 

20,678,472

 
    

55,405,970

 

Media & Entertainment - 4.1%

     

Alphabet, Cl. C

   

11,206

b

18,312,621

 

The Walt Disney Company

   

91,500

 

12,066,105

 
    

30,378,726

 

Pharmaceuticals Biotechnology & Life Sciences - 9.5%

     

Eli Lilly & Co.

   

120,200

 

17,836,478

 

Illumina

   

23,600

b

8,430,392

 

Johnson & Johnson

   

106,800

 

16,384,188

 


STATEMENT OF INVESTMENTS (Unaudited) (continued)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 99.0% (continued)

     

Pharmaceuticals Biotechnology & Life Sciences - 9.5% (continued)

     

Mettler-Toledo International

   

16,900

b

16,406,182

 

Waters

   

57,400

b

12,413,324

 
    

71,470,564

 

Retailing - 8.1%

     

Booking Holdings

   

6,800

b

12,991,060

 

Dollar General

   

93,300

 

18,835,404

 

O'Reilly Automotive

   

35,100

b

16,343,613

 

The TJX Companies

   

224,300

 

12,289,397

 
    

60,459,474

 

Semiconductors & Semiconductor Equipment - 2.0%

     

Texas Instruments

   

106,400

 

15,124,760

 

Software & Services - 22.5%

     

Adobe

   

43,100

b

22,127,109

 

Ansys

   

48,000

b

16,272,480

 

Automatic Data Processing

   

101,000

 

14,048,090

 

Cognizant Technology Solutions, Cl. A

   

263,000

 

17,584,180

 

Jack Henry & Associates

   

67,600

 

11,182,392

 

Manhattan Associates

   

154,400

b

15,015,400

 

Mastercard, Cl. A

   

58,400

 

20,918,296

 

Microsoft

   

109,200

 

24,627,876

 

Oracle

   

241,900

 

13,841,518

 

Paychex

   

172,100

 

13,160,487

 
    

168,777,828

 

Technology Hardware & Equipment - 11.2%

     

Amphenol, Cl. A

   

182,800

 

20,071,440

 

Cisco Systems

   

360,300

 

15,211,866

 

Cognex

   

239,700

 

16,584,843

 

IPG Photonics

   

99,600

b

16,108,308

 

TE Connectivity

   

169,800

 

16,402,680

 
    

84,379,137

 

Transportation - 1.9%

     

Expeditors International of Washington

   

159,700

 

14,115,883

 

Total Common Stocks (cost $396,354,635)

   

742,931,623

 
  

1-Day
Yield (%)

     

Investment Companies - .9%

     

Registered Investment Companies - .9%

     

Dreyfus Institutional Preferred Government Plus Money Market Fund
(cost $7,281,083)

 

0.20

 

7,281,083

c

7,281,083

 

Total Investments (cost $403,635,718)

 

99.9%

 

750,212,706

 

Cash and Receivables (Net)

 

.1%

 

387,993

 

Net Assets

 

100.0%

 

750,600,699

 


a Security, or portion thereof, on loan. At August 31, 2020, the value of the fund’s securities on loan was $5,446,460 and the value of the collateral was $5,690,833, consisting of U.S. Government & Agency securities.

b Non-income producing security.

c Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company’s prospectus.


STATEMENT OF INVESTMENTS
BNY Mellon U.S. Equity Fund

August 31, 2020 (Unaudited)

The following is a summary of the inputs used as of August 31, 2020 in valuing the fund’s investments:

     
 

Level 1 - Unadjusted Quoted Prices

Level 2 - Other Significant Observable Inputs

Level 3 -Significant Unobservable Inputs

Total

Assets ($)

    

Investments in Securities:

  

Equity Securities—Common Stocks

742,931,623

-

-

742,931,623

Investment Companies

7,281,083

-

-

7,281,083

See Statement of Investments for additional detailed categorizations, if any.


The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) is the exclusive reference of authoritative U.S. generally accepted accounting principles (“GAAP”) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund’s financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund’s investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

Level 1—unadjusted quoted prices in active markets for identical investments.

Level 2—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

Level 3—significant unobservable inputs (including the fund’s own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund’s investments are as follows:

Investments in equity securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. For open short positions, asked prices are used for valuation


purposes. Bid price is used when no asked price is available. Registered investment companies that are not traded on an exchange are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices. U.S. Treasury Bills are valued at the mean price between quoted bid prices and asked prices by an independent pricing service (the “Service”) approved by the Board Members (“Board”). These securities are generally categorized within Level 2 of the fair value hierarchy.

The Service’s procedures are reviewed by BNY Mellon under the general supervision of the Board.

Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant American Depository Receipts and futures. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to accurately reflect fair value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded (for example, a foreign exchange or market), but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the fund's Board (the "Board"). Certain factors may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For securities where observable inputs are limited, assumptions about market activity and risk are used and such securities are generally categorized within Level 3 of the fair value hierarchy.

Pursuant to a securities lending agreement with The Bank of New York Mellon, a subsidiary of BNY Mellon and an affiliate of BNY Mellon Investment Adviser, Inc., the fund may lend securities to qualified institutions. It is the fund’s policy that, at origination, all loans are secured by collateral of at least 102% of the value of U.S. securities loaned and 105% of the value of foreign securities loaned. Collateral equivalent to at least 100% of the market value of securities on loan is maintained at all times. Collateral is either in the form of cash, which can be invested in certain money market mutual funds managed by BNY Mellon Investment Adviser Inc., or U.S. Government and Agency securities. The fund is entitled to receive all dividends, interest and distributions on securities loaned, in addition to income earned as a


result of the lending transaction. Should a borrower fail to return the securities in a timely manner, The Bank of New York Mellon is required to replace the securities for the benefit of the fund or credit the fund with the market value of the unreturned securities and is subrogated to the fund’s rights against the borrower and the collateral. Additionally, the contractual maturity of security lending transactions are on an overnight and continuous basis.

At August 31, 2020, accumulated net unrealized appreciation on investments was $346,576,988, consisting of $356,159,925 gross unrealized appreciation and $9,582,937 gross unrealized depreciation.

At August 31, 2020, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Statement of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.